# Dose Escalation Study of Immunomodulatory Nanoparticles

> **NCT04751786** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Radboud University Medical Center** · enrollment: 15 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** PRECIOUS-01

## Key facts

- **NCT ID:** NCT04751786
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-11
- **Primary completion:** 2025-07
- **Final completion:** 2025-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04751786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04751786, "Dose Escalation Study of Immunomodulatory Nanoparticles". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04751786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*